companies / fc-cdci-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-02 json
| total_raised | 2,006,9662.0M | ○ |
|---|---|---|
| founded | 2010 | |
| hq | DOYLESTOWN, Pennsylvania | |
| industry | unknown | |
| stage | null |
Fox Chase Chemical Diversity Center provides contract drug-discovery chemistry services with libraries optimized for CNS, oncology, and inflammation targets. It serves biotech and pharma partners needing medicinal-chemistry support without expanding internal teams. Its proprietary diverse-scaffold library targets CNS penetration and selectivity competitors' generic catalogs don't optimize for.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2024-01-01 | grant | 2,006,9662.0M | null | ○ |
Facebook Pixel
| fact | status | src |
|---|---|---|
| Grant, $2.0M | attributed | ○ |
| existence | sourced | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-10-17provenance_existence: self-reported → sourced, WEB 2026-10-17 | provenance_existence | self-reported → sourced | WEB 2026-10-17 |
Records begin 2026-09-24. all_changes